Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma

European Journal of Human Genetics : EJHG
S K Ylisaukko-OjaL A Aaltonen

Abstract

Germline mutations in the fumarate hydratase (FH) gene were recently shown to predispose to the dominantly inherited syndrome, hereditary leiomyomatosis and renal cell cancer (HLRCC). HLRCC is characterized by benign leiomyomas of the skin and the uterus, renal cell carcinoma, and uterine leiomyosarcoma. The aim of this study was to identify new families with FH mutations, and to further examine the tumor spectrum associated with FH mutations. FH germline mutations were screened from 89 patients with RCC, skin leiomyomas or ovarian tumors. Subsequently, 13 ovarian and 48 bladder carcinomas were analyzed for somatic FH mutations. Two patients diagnosed with ovarian mucinous cystadenoma (two out of 33, 6%) were found to be FH germline mutation carriers. One of the changes was a novel mutation (Ala231Thr) and the other one (435insAAA) was previously described in FH deficiency families. These results suggest that benign ovarian tumors may be associated with HLRCC.

References

Jun 23, 1998·Molecular Genetics and Metabolism·E M CoughlinV E Shih
Mar 18, 1999·The American Journal of Pathology·E AvizienyteL A Aaltonen
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·V LaunonenL A Aaltonen
Feb 28, 2002·Nature Genetics·Ian P M TomlinsonUNKNOWN Multiple Leiomyoma Consortium
Mar 8, 2003·Journal of Medical Genetics·R LehtonenL A Aaltonen
Nov 25, 2003·The Journal of Investigative Dermatology·Amalia Martinez-MirAbraham Zlotogorski
Jan 25, 2005·Clinical and Experimental Dermatology·I ChanJ A McGrath
Feb 23, 2005·Archives of Dermatology·N Afrina AlamIan P M Tomlinson
Mar 12, 2005·Journal of the American Academy of Dermatology·Gary S ChuangAbraham Zlotogorski
Sep 10, 2005·Journal of Inherited Metabolic Disease·J LoeffenJ Smeitink
Sep 13, 2005·Journal of Medical Genetics·H J LehtonenL A Aaltonen
Oct 21, 2005·The Journal of Molecular Diagnostics : JMD·N Afrina AlamTodd Weaver
Nov 29, 2005·Clinical and Experimental Dermatology·G S ChuangA M Christiano

❮ Previous
Next ❯

Citations

Mar 30, 2011·Journal of Inherited Metabolic Disease·Sarah PicaudUdo Oppermann
Oct 12, 2013·Science China. Life Sciences·Hui YangKunLiang Guan
Sep 16, 2008·Annales de dermatologie et de vénéréologie·M MarqueD Bessis
May 12, 2011·Human Mutation·Chris OttolenghiPascale de Lonlay
Nov 1, 2014·Thoracic Cancer·Zongjuan MingShuanying Yang
Mar 4, 2008·Biochimica Et Biophysica Acta·Nuno RaimundoAnu Suomalainen
Jan 22, 2015·American Journal of Clinical Dermatology·Kunal MalikAmor Khachemoune
Jul 28, 2017·Protein & Cell·Nicole M AndersonHui Feng
Jun 21, 2012·Journal of Cutaneous Medicine and Surgery·David SerraAmérico Figueiredo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

The Journal of Clinical Endocrinology and Metabolism
Luis G Carvajal-CarmonaIan P M Tomlinson
International Journal of Cancer. Journal International Du Cancer
S K Ylisaukko-OjaL A Aaltonen
Journal of Cutaneous Medicine and Surgery
Manisha LambaTerence Moyana
© 2022 Meta ULC. All rights reserved